SCWorx signs agreement with healthcare supply chain partner

Published 26/08/2025, 16:02
SCWorx signs agreement with healthcare supply chain partner

TAMPA - SCWorx Corp. (NASDAQ:WORX), a micro-cap company with $2.84 million in trailing twelve-month revenue, announced Tuesday it has entered into a new agreement with an unnamed healthcare supply chain consulting partner to strengthen its software-as-a-service data management program. The company’s stock has declined over 82% year-to-date, according to InvestingPro data.

According to the press release, the partner has experience helping hospitals reduce costs and optimize spend management, with access to products and services at local, regional, and national levels. The partner operates in all 50 states and works with hospitals to optimize direct and indirect procurement.

SCWorx CEO Tim Hannibal said the company’s Foundation product will help the partner "enhance their product line and provide additional value to their healthcare customer." The partner selected SCWorx for its data cleanse, normalization and enrichment services.

The agreement reinforces SCWorx’s position in providing data management solutions specifically designed for hospitals in the United States. The company offers various software modules including Virtual Item Master, contract management, automated rebate management, and data analytics.

The financial terms of the agreement were not disclosed in the announcement.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.